T2-high Asthma, Classified by Sputum mRNA Expression of <i>IL4</i>, <i>IL5</i>, and <i>IL13</i>, is Characterized by Eosinophilia and Severe Phenotype
Asthma is a common chronic disease, with different underlying inflammatory mechanisms. Identification of asthma endotypes, which reflect a variable response to different treatments, is important for more precise asthma management. T2 asthma is characterized by airway inflammation driven by T2 cytoki...
Main Authors: | Matija Rijavec, Tomaž Krumpestar, Sabina Škrgat, Izidor Kern, Peter Korošec |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Life |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-1729/11/2/92 |
Similar Items
-
Heterogeneous Response of Airway Eosinophilia to Anti-IL-5 Biologics in Severe Asthma Patients
by: Maruša Kopač Šokić, et al.
Published: (2022-01-01) -
IL-22 Is Deleterious along with IL-17 in Allergic Asthma but Is Not Detrimental in the Comorbidity Asthma and Acute Pneumonia
by: Amanda Goulart, et al.
Published: (2023-06-01) -
Treatment Challenges in Severe Eosinophilic Asthma: Differential Response to Anti-IL-5 and Anti-IL-5R Therapy
by: Agamemnon Bakakos, et al.
Published: (2021-04-01) -
Sputum IL-26 Is Overexpressed in Severe Asthma and Induces Proinflammatory Cytokine Production and Th17 Cell Generation: A Case–Control Study of Women
by: Louhaichi S, et al.
Published: (2020-02-01) -
IL-4/IL-13 axis as therapeutic targets in allergic rhinitis and asthma
by: Siti Muhamad Nur Husna, et al.
Published: (2022-05-01)